谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Nivolumab Plus Ipilimumab (N+I) in Patients (pts) with Solid Tumors with High Tumor Mutational Burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

John K. Chan,Michael Rothe,Pam K. Mangat, Elizabeth Garrett-Mayer,Timothy Lewis Cannon, Eugene R. Ahn,Paul Swiecicki, Evthokia Hobbs,Reza Nazemzadeh,Maria C. Bell,Peter Joel Hosein,Funda Meric-Bernstam,Dominique C. Hinshaw, Abby Gregory,Gina N. Grantham,Susan Halabi,Richard L. Schilsky

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要